ALEAF — Aleafia Health Share Price
Last trade - 00:00- $0.00m
- $33.06m
- CA$42.85m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -84.56% | ||
| Return on Equity | n/a | ||
| Operating Margin | -56.56% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 3.33 | 16.35 | 44.54 | 43.12 | 42.85 | n/a | n/a | 61.78% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aleafia Health Inc. is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets. The Company is engaged in the production, sale, and distribution of cannabis. It operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada. The Company operates two licensed cannabis production facilities and operates a strategically located distribution center all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals. It markets and sells cannabis products through regulated intermediaries into selected international markets, tactically sells cannabis products into Canadian wholesale markets.
Directors
- Lea Ray NEC (55)
- Tricia Symmes CEO
- Keith White CEX
- Geoff Cowper Smith SEC
- David Pasieka DRC
- Luciano Galasso IND (65)
- Loreto Grimaldi IND (50)
- Michael LeClair IND (64)
- Jon Pereira IND
- Mark Sandler IND (66)
- Carlo Sistilli IND (64)
- Ian Troop IND (61)
- Last Annual
- March 31st, 2023
- Last Interim
- March 31st, 2023
- Incorporated
- February 7th, 2007
- Public Since
- November 29th, 2016
- No. of Employees
- 158
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 403,265,146
- Address
- 85 Basaltic Road, CONCORD, L4K 1G4
- Web
- https://aleafiahealth.com/
- Phone
- +1 4168605665
- Auditors
- Accell Audit & Compliance, P.A
Similar to ALEAF
Acusphere
Pink Sheets on Nasdaq
Adorbs
Pink Sheets on Nasdaq
Agentix
Pink Sheets on Nasdaq
Agrios Global Holdings
Pink Sheets on Nasdaq
Aida Pharmaceuticals
Pink Sheets on Nasdaq
FAQ
As of Today at 19:10 UTC, shares in Aleafia Health are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Aleafia Health last closed at $0.00 and the price had moved by -99.99% over the past 365 days. In terms of relative price strength the Aleafia Health share price has underperformed the S&P500 Index by -99.99% over the past year.
There is no consensus recommendation for this security.
Find out moreAleafia Health does not currently pay a dividend.
Aleafia Health does not currently pay a dividend.
Aleafia Health does not currently pay a dividend.
To buy shares in Aleafia Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Aleafia Health had a market capitalisation of $0.00m.
Here are the trading details for Aleafia Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ALEAF
Based on an overall assessment of its quality, value and momentum Aleafia Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aleafia Health. Over the past six months, its share price has outperformed the S&P500 Index by +3.51%.
As of the last closing price of $0.00, shares in Aleafia Health were trading -100% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aleafia Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aleafia Health's management team is headed by:
- Lea Ray - NEC
- Tricia Symmes - CEO
- Keith White - CEX
- Geoff Cowper Smith - SEC
- David Pasieka - DRC
- Luciano Galasso - IND
- Loreto Grimaldi - IND
- Michael LeClair - IND
- Jon Pereira - IND
- Mark Sandler - IND
- Carlo Sistilli - IND
- Ian Troop - IND